Viral myocarditis: From experimental models to molecular diagnosis in patients

Heart Failure Reviews

Volumn 18, Issue 6, 2013, Pages 683-702

  Pankuweit, Sabine ^a   Klingel, Karin ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Animal models; Molecular diagnosis; Viral myocarditis; Virus prevalence

Indexed keywords

ALPHA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS RNA;

ADENOVIRUS; ADENOVIRUS MYOCARDITIS; ARTICLE; CONGESTIVE CARDIOMYOPATHY; COXSACKIEVIRUS MYOCARDITIS; CYTOTOXICITY; ENCEPHALOMYOCARDITIS MYOCARDITIS; ENTEROVIRUS; EPSTEIN BARR VIRUS; EXPERIMENTAL MODEL; FISH; HEART MUSCLE BIOPSY; HERPES VIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN PARVOVIRUS B19; IN SITU HYBRIDIZATION; INFLUENZA VIRUS; INFLUENZA VIRUS MYOCARDITIS; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; MYOCARDITIS; NONHUMAN; PARVOVIRUS MYOCARDITIS; PATHOGENESIS; PATHOGENICITY; PATHOPHYSIOLOGY; PREVALENCE; REOVIRUS MYOCARDITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME; VIRUS MYOCARDITIS;

ADENOVIRIDAE; ANIMALS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; DNA, VIRAL; ENTEROVIRUS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MOLECULAR DIAGNOSTIC TECHNIQUES; MYOCARDITIS; PARVOVIRUS B19, HUMAN; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 84888205607     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-012-9357-4     Document Type: Article

References (191)

1. Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965-1970
2. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T et al (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639-648
3. Schultz JC, Hilliard AA, Cooper LT Jr, Rihal CS (2009) Diagnosis and treatment of viral myocarditis. Mayo Clin Proc 84:1001-1009
4. Bock CT, Klingel K, Kandolf R (2010) Human parvovirus B19-associated myocarditis. N Engl J Med 362:1248-1249
5. Ruppert V, Meyer T, Balbach A, Richter A, Müller HH, Maisch B, Pankuweit S (2011) German heart failure network. Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy. J Med Virol 83:1818-1825
6. Gdynia G, Schnitzler P, Brunner E, Kandolf R, Bläker H, Daum E, Schnabel P, Schirmacher P, Roth W (2011) Sudden death of an immunocompetent young adult caused by novel (swine origin) influenza A/H1N1-associated myocarditis. Virchows Arch 458:371-376
7. Barbaro G (2005) HIV-associated myocarditis. Heart Fail Clin 1:439-448 (Review)
8. Esfandiarei M, McManus BM (2008) Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol Mech Dis 3:127-155 (Review)
9. Kandolf R, Klingel K, Mertsching H, Canu A, Hohenadl C, Zell R, Reimann BY, Heim A, McManus BM, Foulis AK et al (1991) Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. Eur Heart J 12(Suppl D):49-55 (Review)
10. Klingel K, Rieger P, Mall G, Selinka HC, Huber M, Kandolf R (1998) Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects. Lab Invest 78:1227-1237
11. McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt CJ, Klingel KE, Beisel KW, Kandolf R (1993) Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 68:159-169
12. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ (2004) Direct evidence for a beta1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated Cardiomyopathy. J Clin Invest 113:1419-1429
13. Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S (2008) Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 41(1):35-45 (Review)
14. Ogata M, Satou T, Kawano R, Takakura S, Goto K, Ikewaki J, Kohno K, Ikebe T, Ando T, Miyazaki Y, Ohtsuka E, Saburi Y, Saikawa T, Kadota J (2010) Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transpl 45:129-136
15. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 89:314-318
16. Shi Y, Chen C, Lisewski U, Wrackmeyer U, Radke M, Westermann D, Sauter M, Tschöpe C, Poller W, Klingel K, Gotthardt M (2009) Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol 53:1219-1226
17. Herzum M, Ruppert V, Küytz B, Jomaa H, Nakamura I, Maisch B (1994) Coxsackievirus B3 infection leads to cell death of cardiac myocytes. J Mol Cell Cardiol 26:907-913
18. Chow LH, Beisel KW, McManus BM (1992) Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest 66:24-31
19. Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan Lederer W, Kandolf R, Knowlton KU (1998) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444-1453
20. Badorff C, Lee GH, Lamphear BJ et al (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320-326
21. Luo H, Zhang J, Cheung C, Suarez A, McManus BM, Yang D (2003) Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes. Am J Pathol 163:381-385
22. Esfandiarei M, Suarez A, Amaral A, Si X, Rahmani M, Dedhar S, McManus BM (2006) Novel role for integrin-linked kinase in modulation of coxsackievirus B3 replication and virus-induced cardiomyocyte injury. Circ Res 99:354-361
23. Wong J, Zhang J, Si X, Gao G, Mao I, McManus BM, Luo H (2008) Autophagosome supports coxsackievirus B3 replication in host cells. J Virol 82:9143-9153
24. Wessely R, Klingel K, Knowlton KU, Kandolf R (2001) Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 103:756-761
25. Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN (2004) Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110:3540-3543
26. Weinzierl AO, Szalay G, Wolburg H, Sauter M, Rammensee HG, Kandolf R, Stevanović S, Klingel K (2008) Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. J Virol 82:8149-8160
27. Riad A, Westermann D, Escher F, Becher PM, Savvatis K, Lettau O, Heimesaat MM, Bereswill S, Volk HD, Schultheiss HP, Tschöpe C (2010) Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo. Am J Physiol Heart Circ Physiol 298(6):H2024-H2031
28. Klingel K, Schnorr JJ, Sauter M, Szalay G, Kandolf R (2003) beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis. Am J Pathol 162:1709-1720
29. Opavsky MA, Penninger J, Aitken K, Wen WH, Dawood F, Mak T, Liu P (1999) Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. Circ Res 85:551-558
30. Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard J, Whitton JL (1999) The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol 155:1205-1215
31. Frisancho-Kiss S, Coronado MJ, Frisancho JA, Lau VM, Rose NR, Klein SL, Fairweather D (2009) Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immun 23:649-657
32. Szalay G, Sauter M, Hald J, Weinzierl A, Kandolf R, Klingel K (2006) Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am J Pathol 169:2085-2093
33. Li K, Xu W, Guo Q, Jiang Z, Wang P, Yue Y, Xiong S (2009) Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res 105:353-364
34. Cheung C, Luo H, Yanagawa B, Leong HS, Samarasekera D, Lai JC, Suarez A, Zhang J, McManus BM (2006) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis. Cardiovasc Pathol 15:63-74
35. Cheung C, Marchant D, Walker EK, Luo Z, Zhang J, Yanagawa B, Rahmani M, Cox J, Overall C, Senior RM, Luo H, McManus BM (2008) Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice. Circulation 117:1574-1582
36. Heymans S, Pauschinger M, De Palma A, Kallwellis-Opara A, Rutschow S, Swinnen M, Vanhoutte D, Gao F, Torpai R, Baker AH, Padalko E, Neyts J, Schultheiss HP, Van de Werf F, Carmeliet P, Pinto YM (2006) Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. Circulation 114:565-573
37. Szalay G, Sauter M, Haberland M, Zuegel U, Steinmeyer A, Kandolf R, Klingel K (2009) Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ Res 104:851-859
38. Lang C, Sauter M, Szalay G, Racchi G, Grassi G, Rainaldi G, Mercatanti A, Lang F, Kandolf R, Klingel K (2008) Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis. J Mol Med (Berl) 86:49-60
39. Rother M, Krohn S, Kania G, Vanhoutte D, Eisenreich A, Wang X, Westermann D, Savvatis K, Dannemann N, Skurk C, Hilfiker-Kleiner D, Cathomen T, Fechner H, Rauch U, Schultheiss HP, Heymans S, Eriksson U, Scheibenbogen C, Poller W (2010) Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator. Circulation 122:2688-2698
40. Cunningham MW (2004) T cell mimicry in inflammatory heart disease. Mol Immunol 40:1121-1127
41. Li Y, Heuser JS, Cunningham LC et al (2006) Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 177:8234-8240
42. Fousteri G, Dave A, Morin B, Omid S, Croft M, von Herrath MG (2011) Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis. J Autoimmun 36:210-220
43. Masek-Hammerman K, Miller AD, Lin KC, Mackey J, Weissenböck H, Gierbolini L, Burgos A, Perez H, Mansfield KG. (2011) Epizootic myocarditis associated with encephalomyocarditis virus in a group of rhesus macaques (Macacamulatta). Vet Pathol 28 [Epub ahead of print]
44. Oberste MS, Gotuzzo E, Blair P, Nix WA, Ksiazek TG, Comer JA, Rollin P, Goldsmith CS, Olson J, Kochel TJ (2009) Human febrile illness caused by encephalomyocarditis virus infection, Peru. Emerg Infect Dis 15:640-646
45. Hardarson HS, Baker JS, Yang Z, Purevjav E, Huang CH, Alexopoulou L, Li N, Flavell RA, Bowles NE, Vallejo JG (2007) Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am J Physiol Heart Circ Physiol 292:H251-H258
46. Yamada T, Matsumori A, Sasayama S (1994) Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 89:846-851
47. Tanaka T, Kanda T, McManus BM, Kanai H, Akiyama H, Sekiguchi K, Yokoyama T, Kurabayashi M (2001) Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. J Mol Cell Cardiol 33:1627-1635
48. Higuchi H, Hara M, Yamamoto K, Miyamoto T, Kinoshita M, Yamada T, Uchiyama K, Matsumori A (2008) Mast cells play a critical role in the pathogenesis of viral myocarditis. Circulation 118:363-372
49. Huang CH, Vallejo JG, Kollias G, Mann DL (2009) Role of the innate immune system in acute viral myocarditis. Basic Res Cardiol 104:228-237
50. Takahashi T, Zhu SJ, Sumino H, Saegusa S, Nakahashi T, Iwai K, Morimoto S, Kanda T (2005) Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis. Life Sci 78:195-204
51. Matsumori A (2007) Treatment options in myocarditis: what we know from experimental data and how it translates to clinical trials. Herz 32:452-456 (Review)
52. Sherry B, Li XY, Tyler KL, Cullen JM, Virgin HW 4th (1993) Lymphocytes protect against and are not required for reovirus-induced myocarditis. J Virol 67:6119-6124
53. Sherry B, Baty CJ, Blum MA (1996) Reovirus-induced acute myocarditis in mice correlates with viral RNA synthesis rather than generation of infectious virus in cardiac myocytes. J Virol 70:6709-6715
54. Sherry B, Torres J, Blum MA (1998) Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins. J Virol 72:1314-1323
55. Virgin HW, Dermody TS, Tyler KL (1998) Cellular and humoral immunity to reovirus infection. Curr Top Microbiol Immunol 233:147-161 (Review)
56. Edelmann KH, Richardson-Burns S, Alexopoulou L, Tyler KL, Flavell RA, Oldstone MB (2004) Does Toll-like receptor 3 play a biological role in virus infections? Virology 322:231-238
57. Holm GH, Zurney J, Tumilasci V, Leveille S, Danthi P, Hiscott J, Sherry B, Dermody TS (2007) Retinoic acid-inducible gene-I and interferon-beta promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3. J Biol Chem 282:21953-21961
58. O'Donnell SM, Holm GH, Pierce JM, Tian B, Watson MJ, Chari RS, Ballard DW, Brasier AR, Dermody TS (2006) Identification of an NF-kappaB-dependent gene network in cells infected by mammalian reovirus. J Virol 80:1077-1086
59. Holm GH, Pruijssers AJ, Li L, Danthi P, Sherry B, Dermody TS (2010) Interferon regulatory factor 3 attenuates reovirus myocarditis and contributes to viral clearance. J Virol 84:6900-6908
60. Li L, Sevinsky JR, Rowland MD, Bundy JL, Stephenson JL, Sherry B (2010) Proteomic analysis reveals virus-specific Hsp25 modulation in cardiac myocytes. J Proteome Res 9:2460-2471
61. Miyamoto SD, Brown RD, Robinson BA, Tyler KL, Long CS, Debiasi RL (2009) Cardiac cell-specific apoptotic and cytokine responses to reovirus infection: determinants of myocarditic phenotype. J Card Fail 15:529-539
62. DeBiasi RL, Robinson BA, Leser JS, Brown RD, Long CS, Clarke P (2010) Critical role for death-receptor mediated apoptotic signaling in viral myocarditis. J Card Fail 16:901-910
63. Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA (2003) Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42:466-472
64. Blailock ZR, Rabin ER, Melnick JL (1968) Adenovirus myocarditis in mice. An electron microscopic study. Exp Mol Pathol 9:84-96
65. Kajon AE, Brown CC, Spindler KR (1998) Distribution of mouse adenovirus type 1 in intraperitoneally and intranasally infected adult outbred mice. J Virol 72:1219-1223
66. Guida JD, Fejer G, Pirofski LA, Brosnan CF, Horwitz MS (1995) Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J Virol 69:7674-7681
67. Ashley SL, Welton AR, Harwood KM, Van Rooijen N, Spindler KR (2009) Mouse adenovirus type 1 infection of macrophages. Virology 390:307-314
68. Nie X, Zhang G, Xu D, Sun X, Li Z, Li X, Zhang X, He F, Li Y (2010) The VP1-unique region of parvovirus B19 induces myocardial injury in mice. Scand J Infect Dis 42:121-128
69. Tzang BS, Lin TM, Tsai CC, Hsu JD, Yang LC, Hsu TC (2011) Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. Mol Immunol 48:1518-1524
70. Hoelzer K, Parrish CR (2010) The emergence of parvoviruses of carnivores. Vet Res 41:39
71. Meurs KM, Fox PR, Magnon AL, Liu S, Towbin JA (2000) Molecular screening by polymerase chain reaction detects panleukopenia virus DNA in formalin-fixed hearts from cats with idiopathic cardiomyopathy and myocarditis. Cardiovasc Pathol 9:119-126
72. Agungpriyono DR, Uchida K, Tabaru H, Yamaguchi R, Tateyama S (1999) Subacute massive necrotizing myocarditis by canine parvovirus type 2 infection with diffuse leukoencephalomalacia in a puppy. Vet Pathol 36:77-80
73. Kawai C (1999) From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 99:1091-1100 (Review)
74. Häusler M, Sellhaus B, Scheithauer S, Gaida B, Kuropka S, Siepmann K, Panek A, Berg W, Teubner A, Ritter K, Kleines M (2007) Myocarditis in newborn wild-type BALB/c mice infected with the murine gamma herpesvirus MHV-68. Cardiovasc Res 76:323-330
75. Lenzo JC, Fairweather D, Cull V, Shellam GR, James Lawson CM (2002) Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence. J Mol Cell Cardiol 34:629-640
76. Ritter JT, Tang-Feldman YJ, Lochhead GR, Estrada M, Lochhead S, Yu C, Ashton-Sager A, Tuteja D, Leutenegger C, Pomeroy C (2010) In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis. Cardiovasc Pathol 19:83-93
77. Cull VS, Bartlett EJ, James CM (2002) Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis. Immunology 106:428-437
78. Mamas MA, Fraser D, Neyses L (2008) Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol 130:304-309
79. Bratincsák A, El-Said HG, Bradley JS, Shayan K, Grossfeld PD, Cannavino CR (2010) Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol 55:928-929
80. Pan HY, Yamada H, Chida J, Wang S, Yano M, Yao M, Zhu J, Kido H (2011) Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis. Cardiovasc Res 89:595-603
81. Woo GH, Kim HY, Bae YC, Jean YH, Bak EJ, Kim MJ, Hwang EK, Joo YS (2011) Comparative histopathological characteristics of highly pathogenic avian influenza (HPAI) in chickens and domestic ducks in 2008 Korea. Histol Histopathol 26:167-175
82. Gabriel G, Klingel K, Planz O, Bier K, Herwig A, Sauter M, Klenk HD (2009) Spread of infection and lymphocyte depletion in mice depends on polymerase of influenza virus. Am J Pathol 175:1178-1186
83. Gabriel G, Klingel K, Otte A, Thiele S, Hudjetz B, Arman-Kalcek G, Sauter M, Shmidt T, Rother F, Baumgarte S, Keiner B, Hartmann E, Bader M, Brownlee GG, Fodor E, Klenk HD (2011) Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus. Nat Commun 2:156
84. Durando MM, Birks EK, Hussey SB, Lunn DP (2011) Cardiac troponin I concentrations in ponies challenged with equine influenza virus. J Vet Intern Med 25:339-344
85. Haugland O, Mikalsen AB, Nilsen P, Lindmo K, Thu BJ, Eliassen TM, Roos N, Rode M, Evensen O (2011) Cardiomyopathy syndrome of atlantic salmon (Salmo salar L.) is caused by a double-stranded RNA virus of the Totiviridae family. J Virol 85:5275-5286
86. Fiedler A (1900) Über akute interstitielle Myokarditis. Zentralbl f Med 21:212-213 (Cited by Scott RW, Saphir O (1929-30) Acute isolated myocarditis. Am Heart J 5:129-141.)
87. Woodruff JF (1980) Viral Myocarditis. Am J Pathol 101:428-479
88. Sainani GS, Dekate MP, Rao CP (1975) Heart disease caused by Coxsackie virus B infection. Br Heart J 37:819-823
89. Gordon RB, Lennette EH, Sandrock RS (1959) The varied clinical manifestations of Coxsackie virus infections. Arch Int Med 103:63-75
90. Null FC, Castle CH (1959) Adult pericarditis and myocarditis due to coxsackie virus, group B, type 5. N Engl J Med 26i:937-942
91. Smith WG (1970) Coxsackie B myocarditis in adults. Am Heart J 80:34-46
92. Bell EJ, Grist NR (1970) Further studies of enterovirus infections in cardiac disease and pleurodynia. Scan J Infect Dis 2:1-6
93. Lerner AM, Wilson FM (1973) Virus myocardiomyopathy. Prog Med Virol 15:63-91
94. Medearis DN Jr (1957) Cytomegalic inclusion disease: an analysis of the clinical features based on the literature and 6 additional cases. Pediatrics 19:467-480
95. Lenette DA, Specter S, Thompson KD (eds) (1979) Diagnosis of viral infections: The role of clinical laboratory. University Park Press, Baltimore
96. Grist NR, Reid D (1993) Epidemiology of viral infections of the heart. In: Banatvala JE (ed) Viral infections of the heart. Hodder and Stoughton, London, pp 23-31
97. Mahfoud F, Gärtner B, Kindermann M, Ukena C, Gadomski K, Klingel K, Kandolf R, Böhm M, Kindermann I (2011) Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J 32:897-903
98. Sakakibara S, Konno S (1962) Endomyocardial biopsy. Jpn Heart J 3:537-543
99. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Ehrlich HA, Arnheim N (1985) Enzymatic amplification of β3-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354
100. Pankuweit S, Portig I, Eckhardt H, Crombach M, Hufnagel G, Maisch B (2000) Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease. Herz 25(3):221-226
101. Jackson DP, Lewis FA, Taylor GR, Boylston AW, Quirke P (1990) Tissue extraction of DNA and RNA and analysis by polymerase chain reaction. J Clin Pathol 43:499-504
102. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
103. Maniatis T, Fritsch EF, Sambrook J (1992) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor
104. Rotbart HA (1990) Enzymatic RNA amplification of enteroviruses. J Clin Microbiol 28:438-442
105. Martin AB, Webber S, Fricker J, Jaffe R et al (1994) Acute myocarditis: rapid diagnosis in children. Circulation 90:330-339
106. Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA 84:6272-6276
107. Klingel K, Stephan S, Sauter M, Zell R et al (1996) Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune target cells. J Virol 70:8888-8895
108. Klump WM, Bergmann I, Müller BC, Ameis D, Kandolf R (1990) Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J Virol 64:1573-1583
109. Archard L, Khan M, Soteriou BA et al (1997) Characterisation of coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum Pathol 29:578-584
110. Chapman NM, Tracy S, Gauntt CJ, Fortmüller U (1990) Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridisation. J Clin Microbiol 28:843-850
111. Grasso M, Arbustini E, Silini E et al (1992) Search for Coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am J Cardiol 69:658-664
112. Tracy S, Chapman NM, McManus BM et al (1990) A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol 22:403-414
113. Schowengerdt K, Ni J, Denfield S et al (1997) Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection. Diagnosis using the polymerase chain reaction. Circulation 96:3549-3554
114. Piiparinen H, Vaheri A (1991) Genotyping of herpes simplex viruses by polymerase chain reaction. Arch Virol 119:541-548
115. Weiss SM, Roblin PM, Gaydos CA et al (1996) Failure to detect chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173:957-962
116. Goodman JL, Jurkovic P, Kramber JM, Johnson RC (1991) Molecular detection of persistent borrelia burgdorferi in the urine of patients with active Lyme disease. Infect Immunol 59:269-278
117. Stanek G, Klein J, Bitnner R, Glogar D (1990) Isolation of borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 322:249-252
118. Nakhleh RE, Copenhaver CM, Werdin K (1991) Lack of evidence for involvment of Epstein-Barr virus in the development of 'Quilty' lesion of transplanted hearts: an in situ hybridization study. J Heart Lung Transpl 10:504-507
119. Klingel K, Sauter M, Bock CT, Szalay G, Schnorr JJ, Kandolf R (2004) Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol (Berl) 193(2-3):101-107
120. Kandolf R, Hofschneider PH (1985) Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci USA 82:4818-4822
121. Manaresi E, Gallinella G, Zuffi E, Bonvicini F, Zerbini M, Musiani M (2002) Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory. J Med Virol 67:275-281
122. Harder TC, Hufnagel M, Zahn K, Beutel K, Schmitt H-J, Ullmann U et al (2001) New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections. J Clin Microbiol 39:4413-4419
123. Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M (2001) A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA. J Virol Methods 92:183-191
124. Gruber F, Falkner FG, Dorner F, Hammerle T (2001) Quantitation of viral DNA by real-time PCR applying duplex amplification, internal standardization, and two-color fluorescence detection. Appl Environ Microbiol 67:2837-2839
125. Servant A, Laperche S, Lallemand F, Marinho V, De Maur G, Meritet JF, Garbarg-Chenon A (2002) Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 76:9124-9134
126. Hokynar K, Soderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio EK, Hedman K (2002) A new parvovirus genotype persistent in human skin. Virology 302:224-228
127. Nguyen QT, WongS HeegaardED, Brown KE (2002) Identification and characterization of a second novel human erythrovirus variant A6. Virology 301:374-380
128. Heegaard ED, Brown KE (2002) Human parvovirus B 19. Clin Microbiol Rev 15:485-505
129. Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S (2005) Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol 75(1):161-169
130. Yajima T, Knowlton KU (2009) Viral myocarditis: from the perspective of the virus. Circulation 119:2615-2624
131. Bowles NE, Rose ML, Taylor P et al (1989) End-stage dilated cardiomyopathy persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 80:1128-1136
132. Tracy S, Wiegand V, McManus B et al (1990) Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis. JACC 15:1688-1694
133. Jin O, Sole M, Butany JW et al (1990) Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 82:8-16
134. Weiss L, Mohaved L, Billingham ME, Cleary ML (1991) Detection of coxsackie B3 RNA in myocardial tissues by polymerase chain reaction. Am J Pathol 138:497-503
135. Kandolf R, Klingel K, Zell R et al (1993) Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology 35:140-150
136. Petitjan J, Kopecka H, Freymuth F et al (1992) Detection of enteroviruses in endomyocardial biopsy by molecular approach. J Med Virol 37:76-82
137. Pauschinger M, Dörner G, Meissner G et al (1994) Enteroviral RNA detection by polymerase chain reaction (PCR) in cardiac muscle biopsies of patients with myocarditis or dilated cardiomyopathy. J Am Coll Cardiol 2:880-884
138. Bowles N, Towbin J (1996) Viral heart muscle disease in children. Newslett Sci Counc Cardiomyopathies 11:4-5
139. Talwar KK, Thatai D, Kannath P et al (1996) Enteroviral detection by polymerase chain reaction technique in endomyocardial biopsy specimen: an initial study. Indian Heart J 48:479-480
140. Maisch B, Schönian U, Hufnagel G, Pankuweit S (1997) Enteroviral persistence in myocarditis and dilated cardiomyopathy. Eur Heart J 18:593
141. Pauschinger M, Phan MD, Dörner A et al (1997) Detection of enteroviral RNA replicative intermediates in endomyocardial biopsies: indication of viral replication in the human heart. Eur Heart J 18:594A
142. Kuhl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with idiopathic left ventricular dysfunction. Circulation 111:887-893
143. Pankuweit S, Ruppert V, Eckhardt H, Strache D, Maisch B (2005) Pathophysiology and etiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B 19. J Vet Med B Infect Dis Vet Public Health 52(7-8):344-347
144. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114(15):1581-1590
145. Kandolf R, Bültmann B, Klingel K, Bock CT (2008) Molecular mechanisms and consequences of cardiac viral infections. Pathologe 29(Suppl 2):112-117
146. Pauschinger M, Dörner A, Kühl U et al (1999) Enteroviral replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889-895
147. Chapman M, Kim KS (2008) Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol 323:275-292
148. Kytö V, Vuorinen T, Saukko P, Lautenschlager I, Lignitz E, Saraste A, Voipio-Pulkki LM (2005) Cytomegalovirus infection of the heart is common in patients with fatal myocarditis. Clin Infect Dis 40(5):683-688
149. Maisch B, Schönian U, Crombach M et al (1993) Cytomegalovirus associated inflammatory heart muscle disease. Scan J Infect Dis suppl 88:135-148
150. Schönian U, Crombach M, Maisch B (1993) Assessment of cytomegalovirus DNA and protein expression in patients with myocarditis. Clin Immun Immunpathol 68:229-233
151. Towbin JA (1996) Diagnosis and management of myocarditis in children. Newsletter of the Scientific Council on Cardiomyopathies 11:8
152. Maisch B, Pausch R, Hufnagel G, Schönian U (1997) The neglected role of DNA viruses in chronic myocarditis and dilated cardiomyopathy. Eur Heart J 18:515
153. Bergelson JM, Cunningham JA, Droguett G et al (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323
154. Tomko RP, Xu R, Philipson L (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 94:3352-3356
155. Hufnagel G, Busse C, Ische B, Maisch B (1997) Detection of adenoviral DNA in endomyocardial biopsies of adult patients with myocarditis and dilated cardiomyopathy. Eur Heart J 18:515
156. Pauschinger M, Bowles NE, Fuentes-Garcia FJ et al (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99:1348-1354
157. Rohayem J, Dinger J, Fischer R et al (2001) Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol 39:4585-4587
158. Heegaard ED, Eiskjaer H, Baandrup U et al (1998) Case report: parvovirus B19 infection associated with myocarditis following adult cardiac transplantation. Scand J Infect Dis 30:607-610
159. Chia JKS (1996) Myopericarditis due to parvovirus B19 in an adult. Clin Infect Dis 23:200-201
160. Schwarz TF, Wiersbitzky S, Pambor M (1994) Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum. J Med Virol 43:171-174
161. Gabriel SE, Espy M, Erdman DD et al (1999) The role of parvovirus B19 in the pathogenesis of giant cell arteritis. Arthritis Rheum 42:1255-1258
162. Nigro G, Bastianon V, Colloridi V et al (2000) Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 31:65-69
163. Sokal EM, Melchior M, Cornu C et al (1998) Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet 352:1739-1741
164. Enders M, Klingel K, Weidner A, Baisch C, Kandolf R, Schalasta G, Enders G (2010) Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection. J Clin Virol 49:163-168
165. Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114-117
166. Porter HJ, Quantrill AM, Fleming KA (1998) B19 parvovirus infection of myocardial cells. Lancet 1:535-536
167. Pankuweit S, Moll R, Baantrup U, Portig I, Hufnagel G, Maisch B (2003) Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol 34:497-500
168. Klein RM, Jiang H, Niederacher D, Adams O, Du M, Horlitz M, Schley P, Marx R, Lankisch MR, Brehm MU, Strauer BE, Gabbert HE, Scheffold T, Gülker H (2004) Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction. Z Kardiol 93(4):300-309
169. Kühl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck CP, Seeberg B, Krautwurm L, Poller W, Schultheiss HP, Kandolf R (2003) Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108(8):945-950
170. Bültmann BD, Klingel K, Sotlar K, Bock CT, Baba HA, Sauter M, Kandolf R (2003) Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34:92-95
171. Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K, Schaal S, Kamvissi V, Bornstein SR, Schwanebeck U, Modrow S (2009) Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis 49:1660-1666
172. Lotze U, Egerer R, Glück B, Zell R, Sigusch H, Erhardt C, Heim A, Kandolf R, Bock T, Wutzler P, Figulla HR (2010) Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury. J Med Virol 82:1449-1457
173. Corcioli F, Zakrzewska K, Rinieri A, Fanci R, Innocenti M, Civinini R, De Giorgi V, Di Lollo S, Azzi A (2008) Tissue persistence of parvovirus B19 genotypes in asymptomatic persons. J Med Virol 80:2005-2011
174. Schenk T, Enders M, Pollak S, Hahn R, Huzly D (2009) High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol 47:106-110
175. Stewart GC, Lopez-Molina J, Gottumukkala RV, Rosner GF, Anello MS, Hecht JL, Winters GL, Padera RF, Baughman KL, Lipes MA (2011) Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure. Circ Heart Fail 4(1):71-78
176. Schmidt-Lucke C, Spillmann F, Bock T, Kühl U, Van Linthout S, Schultheiss HP, Tschöpe C (2010) Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection. J Infect Dis 201:936-945
177. Zafrir B, Aviv A, Reichman N, Flatau E (2005) Epstein-Barr virus associated pericarditis and pericardial effusion: case report and diagnostic aspects. Eur J Intern Med 16:528-530
178. Roubille F, Gahide G, Moore-Morris T, Granier M, Davy JM, Vernhet H, Piot C (2008) Epstein Barr virus (EBV) and acute myopericarditis in an immunocompetent patient: first demonstrated case and discussion. Intern Med 47(7):627-629
179. Chang YL, Parker ME, Nuovo G, Miller JB (2009) Human herpesvirus 6-related fulminant myocarditis and hepatitis in an immunocompetent adult with fatal outcome. Hum Pathol 40(5):740-745
180. Leveque N, Boulagnon C, Brasselet C, Lesaffre F, Boutolleau D, Metz D, Fornes P, Andreoletti L (2011) A fatal case of Human Herpesvirus 6 chronic myocarditis in an immunocompetent adult. J Clin Virol 52(2):142-145
181. Liao YC, Hsieh YC, Chang WC, Huang JL, Ting CT, Wu TJ (2011) Fulminant myocarditis in an adult with 2009 pandemic influenza A (H1N1 influenza) infection. J Chin Med Assoc 74(3):130-133
182. Moulik M, Breinholt JP, Dreyer WJ, Kearney DL, Price JF, Clunie SK, Moffett BS, Kim JJ, Rossano JW, Jefferies JL, Bowles KR, O'Brian Smith E, Bowles NE, Denfield SW, Towbin JA (2010) Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J Am Coll Cardiol 56(7):582-592
183. Shaw T, Elliot P, McKenna WJ (2002) Dilated cardiomyopathy: a genetical heterogeneous disease. Lancet 360:654-655
184. Mason JW (2003) Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 60:5-10
185. Maekawa Y, Ouzounian M, Opavsky MA, Liu PP (2007) Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. Circulation 115(1):5-8
186. Linde A, Mosier D, Blecha F, Melgarejo T (2007) Innate immunity and inflammation-new frontiers in comparative cardiovascular pathology. Cardiovasc Res 73(1):26-36
187. Gorbea C, Makar KA, Pauschinger M, Pratt G, Bersola JL, Varela J, David RM, Banks L, Huang CH, Li H, Schultheiss HP, Towbin JA, Vallejo JG, Bowles NE (2010) A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem 285:23208-23223
188. Mann DL (2011) The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res 108(9):1133-1145
189. Fuse K, Chan G, Liu Y, Gudgeon P, Husain M, Chen M, Yeh WC, Akira S, Liu PP (2005) Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3 induced myocarditis, and influences type I interferon production. Circulation 112:2276-2285
190. Mann DL, Topkara VK, Evans S, Barger PM (2010) Innate immunity in the adult mammalian heart: for whom the cell tolls. Trans Am Clin Climatol Assoc 121:34-50
191. Schultheiss HP, Kühl U, Cooper LT (2011) The management of myocarditis. Eur Heart J 32:2616-2625